Crossmark

Pharmacoeconomic evaluation of micafungin versus caspofungin as definitive therapy for candidaemia and invasive candidiasis (IC) in Turkey

Crossref DOI link: https://doi.org/10.1007/s10096-017-3147-9

Published Online: 2017-11-28

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Neoh, C. F.

Senol, E.

Kara, A.

Dinleyici, E. C.

Turner, S. J.

Kong, D. C. M.
License Information

License valid from 2017-11-28